Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome (COHELLP)
Postpartum Dexamethasone for Women With Class I HELLP Syndrome: a Double-blind, Placebo-controled, Randomized Clinical Trial
Sponsor: Instituto Materno Infantil Prof. Fernando Figueira
Terminated
The speed of recruitment was slower than anticipated.
Other terminated trials from Instituto Materno Infantil Prof. Fernando Figueira
See all terminations from Instituto Materno Infantil Prof. Fernando Figueira
A PHASE4 clinical study on HELLP Syndrome, this trial is terminated or withdrawn. The trial is conducted by Instituto Materno Infantil Prof. Fernando Figueira and has accumulated 8 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jul 2019 — Jan 2021 [monthly]
Terminated PHASE4
Status: Active Not Recruiting → Terminated
-
Mar 2019 — Jul 2019 [monthly]
Active Not Recruiting PHASE4
▶ Show 3 earlier versions
-
Sep 2018 — Mar 2019 [monthly]
Active Not Recruiting PHASE4
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Instituto Materno Infantil Prof. Fernando Figueira
For direct contact, visit the study record on ClinicalTrials.gov .